• Explore /
  • Poster
  • / Phase 2 trial of three schedules of CUE-101 administered before surgery or chemoradiotherapy in HLA-A*0201 positive patients with HPV16+ OPSCC.

Phase 2 trial of three schedules of CUE-101 administered before surgery or chemoradiotherapy in HLA-A*0201 positive patients with HPV16+ OPSCC.

Abstract Poster

Authors

null

Jesse Meir Zaretsky

Washington University School of Medicine, Department of Medicine, Division of Oncology, St. Louis, MO

Jesse Meir Zaretsky , Jessica C. Ley , Peter John Oppelt , Riley Mullins , Thomas Barrett , Ryan Jackson , Patrik Pipkorn , Randal C Paniello , Jason Rich , Jingxia Liu , Sarah Pennock , Jared Cohen , Wade Thorstad , Steven N Quayle , Raymond Moniz , Apollina Goel , Matteo Levisetti , Anish Suri , Sidharth Puram , Douglas Adkins

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Local-Regional Disease

Clinical Trial Registration Number

NCT04852328

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr TPS6109)

DOI

10.1200/JCO.2023.41.16_suppl.TPS6109

Abstract #

TPS6109

Poster Bd #

97a

Abstract Disclosures

Similar Posters

First Author: Christine H. Chung

Poster

2024 ASCO Annual Meeting

<span>Phase IIA study of high-affinity TCR-T (TAEST16001) targeting NY-ESO-1 in soft tissue sarcoma.</span>

Phase IIA study of high-affinity TCR-T (TAEST16001) targeting NY-ESO-1 in soft tissue sarcoma.

First Author: Jiayong Liu

First Author: Suzanne Phillips

First Author: Christine H. Chung